SOTAC PHARMACEUTICALS
|
SOTAC PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹11 Cr | ₹8.05 Cr | ₹2.30 Cr | ₹2.30 Cr | ₹2.30 Cr |
Equity - Authorised | ₹12 Cr | ₹12 Cr | ₹2.30 Cr | ₹2.30 Cr | ₹2.30 Cr |
Equity - Issued | ₹11 Cr | ₹8.05 Cr | ₹2.30 Cr | ₹2.30 Cr | ₹2.30 Cr |
Equity Paid Up | ₹11 Cr | ₹8.05 Cr | ₹2.30 Cr | ₹2.30 Cr | ₹2.30 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | ₹9.47 Cr | - | - | - |
Total Reserves | ₹34 Cr | ₹1.94 Cr | ₹4.32 Cr | ₹0.19 Cr | ₹0.76 Cr |
Securities Premium | ₹28 Cr | - | ₹0.17 Cr | - | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹5.88 Cr | ₹1.60 Cr | ₹4.00 Cr | - | - |
General Reserves | - | - | - | - | - |
Other Reserves | ₹0.31 Cr | ₹0.34 Cr | ₹0.15 Cr | ₹0.19 Cr | ₹0.76 Cr |
Reserve excluding Revaluation Reserve | ₹34 Cr | ₹1.94 Cr | ₹4.32 Cr | ₹0.19 Cr | ₹0.76 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹45 Cr | ₹19 Cr | ₹6.62 Cr | ₹2.49 Cr | ₹3.06 Cr |
Minority Interest | ₹4.07 Cr | ₹0.23 Cr | - | ₹0.07 Cr | ₹1.66 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹11 Cr | ₹7.64 Cr | ₹0.97 Cr | ₹9.28 Cr | ₹5.24 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹14 Cr | ₹11 Cr | ₹2.20 Cr | ₹11 Cr | ₹5.90 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-2.85 Cr | ₹-3.45 Cr | ₹-1.23 Cr | ₹-1.30 Cr | ₹-0.66 Cr |
Unsecured Loans | ₹1.37 Cr | ₹0.13 Cr | - | - | ₹0.91 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹1.37 Cr | ₹0.13 Cr | - | - | ₹0.91 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-1.43 Cr | ₹0.28 Cr | ₹-0.02 Cr | ₹0.05 Cr | ₹0.16 Cr |
Deferred Tax Assets | ₹1.43 Cr | - | ₹0.02 Cr | - | - |
Deferred Tax Liability | - | ₹0.28 Cr | - | ₹0.05 Cr | ₹0.16 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.14 Cr | ₹0.10 Cr | ₹0.06 Cr | ₹0.04 Cr | ₹0.02 Cr |
Total Non-Current Liabilities | ₹11 Cr | ₹8.14 Cr | ₹1.01 Cr | ₹9.37 Cr | ₹6.33 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹29 Cr | ₹25 Cr | ₹20 Cr | ₹13 Cr | ₹11 Cr |
Sundry Creditors | ₹29 Cr | ₹25 Cr | ₹20 Cr | ₹13 Cr | ₹11 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹4.18 Cr | ₹7.53 Cr | ₹1.50 Cr | ₹2.75 Cr | ₹1.03 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.04 Cr | ₹3.58 Cr | ₹0.02 Cr | ₹1.37 Cr | ₹0.29 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹3.14 Cr | ₹3.96 Cr | ₹1.47 Cr | ₹1.39 Cr | ₹0.75 Cr |
Short Term Borrowings | ₹9.88 Cr | ₹11 Cr | ₹5.19 Cr | ₹6.55 Cr | ₹6.64 Cr |
Secured ST Loans repayable on Demands | ₹9.85 Cr | ₹11 Cr | ₹5.19 Cr | ₹3.78 Cr | ₹3.65 Cr |
Working Capital Loans- Sec | ₹9.85 Cr | ₹11 Cr | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-9.83 Cr | ₹-11 Cr | - | ₹2.77 Cr | ₹2.99 Cr |
Short Term Provisions | ₹0.78 Cr | ₹2.06 Cr | ₹1.18 Cr | ₹0.45 Cr | ₹0.29 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.40 Cr | ₹1.60 Cr | ₹0.98 Cr | ₹0.16 Cr | ₹0.20 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.38 Cr | ₹0.47 Cr | ₹0.20 Cr | ₹0.29 Cr | ₹0.09 Cr |
Total Current Liabilities | ₹44 Cr | ₹46 Cr | ₹28 Cr | ₹23 Cr | ₹19 Cr |
Total Liabilities | ₹104 Cr | ₹74 Cr | ₹35 Cr | ₹35 Cr | ₹30 Cr |
ASSETS | |||||
Gross Block | ₹46 Cr | ₹33 Cr | ₹14 Cr | ₹22 Cr | ₹19 Cr |
Less: Accumulated Depreciation | ₹10 Cr | ₹6.99 Cr | ₹4.75 Cr | ₹5.43 Cr | ₹2.84 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹36 Cr | ₹26 Cr | ₹8.80 Cr | ₹17 Cr | ₹16 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹5.12 Cr | ₹0.04 Cr | - | - | - |
Non Current Investments | ₹2.10 Cr | - | ₹0.39 Cr | ₹0.13 Cr | - |
Long Term Investment | ₹2.10 Cr | - | ₹0.39 Cr | ₹0.13 Cr | - |
Quoted | - | - | - | - | - |
Unquoted | ₹2.10 Cr | - | ₹0.39 Cr | ₹0.13 Cr | - |
Long Term Loans & Advances | ₹0.53 Cr | ₹0.54 Cr | ₹0.17 Cr | ₹0.66 Cr | ₹0.64 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹43 Cr | ₹27 Cr | ₹9.36 Cr | ₹17 Cr | ₹17 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | ₹0.17 Cr | ₹0.16 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | ₹0.17 Cr | ₹0.16 Cr |
Inventories | ₹18 Cr | ₹14 Cr | ₹5.40 Cr | ₹4.83 Cr | ₹2.32 Cr |
Raw Materials | ₹11 Cr | ₹7.79 Cr | ₹3.95 Cr | ₹3.83 Cr | ₹1.84 Cr |
Work-in Progress | ₹0.82 Cr | ₹1.30 Cr | ₹1.35 Cr | ₹0.88 Cr | ₹0.47 Cr |
Finished Goods | - | - | - | - | - |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹6.58 Cr | ₹4.56 Cr | ₹0.10 Cr | ₹0.12 Cr | ₹0.02 Cr |
Sundry Debtors | ₹26 Cr | ₹15 Cr | ₹12 Cr | ₹5.89 Cr | ₹6.96 Cr |
Debtors more than Six months | ₹1.08 Cr | ₹0.80 Cr | ₹3.03 Cr | ₹1.91 Cr | ₹1.45 Cr |
Debtors Others | ₹25 Cr | ₹14 Cr | ₹9.23 Cr | ₹3.97 Cr | ₹5.51 Cr |
Cash and Bank | ₹3.42 Cr | ₹9.68 Cr | ₹0.03 Cr | ₹0.27 Cr | ₹0.43 Cr |
Cash in hand | ₹0.40 Cr | ₹0.18 Cr | ₹0.03 Cr | ₹0.24 Cr | ₹0.01 Cr |
Balances at Bank | ₹3.01 Cr | ₹9.50 Cr | - | ₹0.03 Cr | ₹0.42 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.14 Cr | ₹0.73 Cr | ₹0.07 Cr | ₹0.67 Cr | ₹0.34 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.14 Cr | ₹0.06 Cr | ₹0.01 Cr | ₹0.01 Cr | - |
Other current_assets | - | ₹0.68 Cr | ₹0.06 Cr | ₹0.66 Cr | ₹0.34 Cr |
Short Term Loans and Advances | ₹13 Cr | ₹8.34 Cr | ₹8.14 Cr | ₹5.53 Cr | ₹3.54 Cr |
Advances recoverable in cash or in kind | ₹1.58 Cr | ₹0.90 Cr | ₹0.74 Cr | ₹0.01 Cr | ₹0.01 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹11 Cr | ₹7.45 Cr | ₹7.40 Cr | ₹5.52 Cr | ₹3.52 Cr |
Total Current Assets | ₹61 Cr | ₹47 Cr | ₹26 Cr | ₹17 Cr | ₹14 Cr |
Net Current Assets (Including Current Investments) | ₹17 Cr | ₹1.33 Cr | ₹-1.73 Cr | ₹-5.41 Cr | ₹-5.59 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹104 Cr | ₹74 Cr | ₹35 Cr | ₹35 Cr | ₹30 Cr |
Contingent Liabilities | ₹0.46 Cr | - | ₹0.40 Cr | - | - |
Total Debt | ₹25 Cr | ₹22 Cr | ₹7.39 Cr | ₹17 Cr | ₹13 Cr |
Book Value | - | 12.41 | 28.79 | 10.84 | 13.29 |
Adjusted Book Value | 40.96 | 12.41 | 8.23 | 3.10 | 3.80 |
Compare Balance Sheet of peers of SOTAC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOTAC PHARMACEUTICALS | ₹119.9 Cr | -2.7% | -13.9% | -19.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
SOTAC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOTAC PHARMACEUTICALS | -2.7% |
-13.9% |
-19.6% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses